Viral IL-10 Gene Transfer Inhibits DTH Responses to Soluble Antigens: Evidence for Involvement of Genetically Modified Dendritic Cells and Macrophages

This publication has 27 references indexed in Scilit:

• Effective Treatment of Established Murine Collagen-Induced Arthritis by Systemic Administration of Dendritic Cells Genetically Modified to Express IL-4
  The Journal of Immunology, 2001
• Future of adenoviruses in the gene therapy of arthritis
  Arthritis Research & Therapy, 2001
• DIFFERENTIAL EFFECTS OF EXOGENOUS INTERLEUKIN-10 ON CARDIAC ALLOGRAFT SURVIVAL1,2
  Transplantation, 1999
• Modulation of virus‐induced delayed‐type hypersensitivity by plasmid DNA encoding the cytokine interleukin‐10
  Immunology, 1998
• Direct adenovirus-mediated gene transfer of interleukin 1 and tumor necrosis factor α soluble receptors to rabbit knees with experimental arthritis has local and distal anti-arthritic effects
  Proceedings of the National Academy of Sciences, 1998
• A critical role for transforming growth factor-beta but not interleukin 4 in the suppression of T helper type 1-mediated colitis by CD45RB(low) CD4+ T cells.
  The Journal of Experimental Medicine, 1996
• Immunosuppressive and Anti-inflammatory Properties of Interleukin 10
  Annals of Medicine, 1995
• Interleukin‐4 and interleukin‐10 synergize to inhibit cell‐mediated immunity in vivo
  European Journal of Immunology, 1993
• Interleukin 10(IL-10) inhibits cytokine synthesis by human monocytes: an autoregulatory role of IL-10 produced by monocytes.
  The Journal of Experimental Medicine, 1991
• Homology of Cytokine Synthesis Inhibitory Factor (IL-10) to the Epstein-Barr Virus Gene BCRFI
  Science, 1990